Neurocrine Biosciences (NBIX) Stock News
$NBIX · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Neurocrine Biosciences (NBIX) in the past 30 days. Neurocrine Biosciences’ next earnings report is scheduled for Tuesday, Oct 27.
The wire on $NBIX
newest first · updated · direct subject stories onlyNeurocrine Biosciences appoints Eiry W. Roberts as Chief Medical Officer, Sanjay Keswani departs
Eiry W. Roberts returns as CMO effective immediately, replacing Sanjay Keswani who leaves by mutual agreement. Roberts previously served as CMO from 2018-2025 and led key development programs including INGREZZA expansion and the crinecerfont program that led to CRENESSITY approval.
neutral 50 · impact 30The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
BORSAPLUSNews on Price · Earnings read · Flow and ownership · Options context
Create a free account · no card Neurocrine Biosciences (NBIX) stock: common questions
What is the latest Neurocrine Biosciences stock news?
The highest-impact NBIX story BORSA published in the past 30 days:
· Neurocrine Biosciences appoints Eiry W. Roberts as Chief Medical Officer, Sanjay Keswani departs